World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
65502
World Ranking
4848
National Ranking
2629

Lisa A. Carey publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lisa A. Carey sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 592 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lisa A. Carey D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lisa A. Carey sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lisa A. Carey is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research spans significant areas of medicine, particularly focusing on oncology and related fields. The scientist has contributed extensively to topics such as breast cancer therapies, HER2/EGFR in cancer research, cancer treatment and pharmacology, and cancer genomics and diagnostics.

The researcher's main fields of study include Medicine, with a substantial output in Biochemistry, Genetics, and Molecular Biology. Subfields of study where they have made notable contributions include Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging, and Molecular Biology.

Lisa A. Carey's work covers several key research topics, including:

  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Breast Cancer Treatment Studies
  • Cancer Treatment and Pharmacology
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Estrogen and related hormone effects

Their publication record features papers in prominent venues such as UNC Libraries, Journal of Clinical Oncology, Cancer Research, Annals of Oncology, and Clinical Cancer Research. The number of publications in these venues reflects a focus on clinical oncology and cancer research.

Recent publications authored or co-authored by Lisa A. Carey include:

  • "Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer," 2021, New England Journal of Medicine
  • "Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update," 2020, Journal of Clinical Oncology
  • "Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline," 2021, Journal of Clinical Oncology
  • "Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021," 2021, Annals of Oncology
  • "Triple negative breast cancer: Pitfalls and progress," 2022, npj Breast Cancer

Frequent co-authors collaborating with Lisa A. Carey include:

  • Charles M. Perou
  • Eric P. Winer
  • Ann H. Partridge
  • Sara M. Tolaney
  • Hope S. Rugo

Best Publications

  • Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

    Lisa A. Carey;Charles M. Perou;Chad A. Livasy;Lynn G. Dressler

  • The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

    Lisa A. Carey;E. Claire Dees;Lynda Sawyer;Lisa Gatti

  • The molecular portraits of breast tumors are conserved across microarray platforms

    Zhiyuan Hu;Cheng Fan;Daniel S Oh;JS Marron

  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    F. Cardoso;A. Costa;E. Senkus;M. Aapro

  • Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

    Aditya Bardia;Sara A Hurvitz;Sara M Tolaney;Delphine Loirat

  • Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?

    James D. Brenton;Lisa A. Carey;Ahmed Ashour Ahmed;Carlos Caldas

  • Epidemiology of basal-like breast cancer

    Robert C. Millikan;Beth Newman;Chiu Kit Tse;Patricia G. Moorman

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

    William M. Sikov;Donald A. Berry;Charles M. Perou;Baljit Singh

  • Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.

    Rashmi K Murthy;Sherene Loi;Alicia Okines;Elisavet Paplomata

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.

    Kimberly H. Allison;M. Elizabeth H. Hammond;Mitchell Dowsett;Shannon E. McKernin

  • Triple-negative breast cancer: disease entity or title of convenience?

    Lisa Carey;Eric Winer;Giuseppe Viale;David Cameron

  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

    Sara M. Tolaney;William T. Barry;Chau T. Dang;Denise A. Yardley

  • Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

    Ayca Gucalp;Ayca Gucalp;Sara Tolaney;Steven J. Isakoff;James N. Ingle

  • Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer

    Carey Kernodle Anders;Lisa A Carey

  • Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals.

    Annette Flanagin;Lisa A. Carey;Phil B. Fontanarosa;Stephanie G. Phillips

  • Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

    Aleix Prat;Barbara Adamo;Maggie C.U. Cheang;Carey K. Anders

  • Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

    Larissa A. Korde;Mark R. Somerfield;Lisa A. Carey;Jennie R. Crews

  • TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

    Lisa A. Carey;Hope S. Rugo;P. Kelly Marcom;Erica L. Mayer

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.

    H J Burstein;G Curigliano;B Thürlimann;W P Weber

Frequent Co-Authors

Charles M. Perou
Charles M. Perou University of North Carolina at Chapel Hill
Eric P. Winer
Eric P. Winer Yale University
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Clifford A. Hudis
Clifford A. Hudis Memorial Sloan Kettering Cancer Center
Joel S. Parker
Joel S. Parker University of North Carolina at Chapel Hill
Ann H. Partridge
Ann H. Partridge Harvard University
Ian E. Krop
Ian E. Krop Harvard University
Antonio C. Wolff
Antonio C. Wolff Johns Hopkins University
Sara M. Tolaney
Sara M. Tolaney Harvard University
Aleix Prat
Aleix Prat University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA typically requires on-campus clinical work, there are alternative online pathways for those interested in the healthcare field. For individuals looking to develop leadership and management skills in healthcare without direct patient care, pursuing cahme accredited online healthcare administration programs can be a strong choice. These programs offer flexible, reputable options to build expertise in healthcare management.

Nurses seeking career advancement may consider an rn to bsn online without clinicals program, allowing registered nurses to earn a bachelor’s degree while balancing work and family obligations. For even higher credentials, online doctoral nursing programs are growing in popularity. There are several dnp online programs that accelerate completion for experienced nurses.

Those searching for more accessible doctoral options should explore easiest online dnp programs, which can reduce barriers to doctoral education in nursing. Whether your goal is administration, leadership, or advanced clinical practice, these online degrees expand your opportunities and can complement a medical education.

Best Scientists Citing Lisa A. Carey

Trending Scientists

Recently Published Articles